Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.
about
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.Biomarkers in the prevention and follow-up of workers exposed to asbestos.Serum mesothelin and other biomarkers: what have we learned in the last decade?Biomarkers in malignant pleural mesothelioma: current status and future directions.Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.
P2860
Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@en
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@nl
type
label
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@en
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@nl
prefLabel
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@en
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Diagnostic and prognostic util ...... Evidence from a meta-analysis.
@en
P2093
Dongxu Pei
Xiaolan Guo
Xiaoxia Guo
Xinwei Liu
Yongwei Li
P2860
P304
13030-13038
P356
10.18632/ONCOTARGET.14712
P407
P577
2017-01-18T00:00:00Z